Team of more than 20 epileptologists, neurologists, neurosurgeons and others are committed to improving outcomes for people with epilepsy.
Small movements, huge steps for Spinal Muscular Atrophy patient enrolled in clinical trial
An investigational medication device yields dramatic firsts in a CHOC clinical trial for a patient with a motor neuron disorder.
Dr. Peter Anderson, globally known expert on newborn brain development, joins CHOC and UCI
Dr. Anderson specializes in identifying ways to improve the outcomes of ill neonates and implementing interventions to optimize brain growth and neurodevelopmental outcomes.
CHOC earns national distinction as Batten Disease Center of Excellence
CHOC is one of five Batten Disease Centers of Excellence across the country and the only one on the West Coast.
Leading research into early rehabilitation for neonatal strokes
Neonatal stroke may lead to cerebral palsy, but early rehabilitation can limit disability. CHOC researchers are at the forefront of improving outcomes.
Surveillance program for patients with congenital heart disease a success
In novel program, congenital heart disease patients are being monitored at CHOC for longtime success.
